Pharmacoeconomics of atrial fibrillation and stroke prevention.

The American journal of managed care

Volumn 10, Issue 3 Suppl, 2004, Pages

  Bushnell, Cheryl D ^a   Matchar, David B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

CEREBROVASCULAR ACCIDENT; COST BENEFIT ANALYSIS; ECONOMICS; HEART ATRIUM FIBRILLATION; HUMAN; PHARMACOECONOMICS; REVIEW; UNITED STATES;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; HUMANS; UNITED STATES;

EID: 2942590958     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)